Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort. [electronic resource] by
- Kandel, M
- Allayous, C
- Dalle, S
- Mortier, L
- Dalac, S
- Dutriaux, C
- Leccia, M T
- Guillot, B
- Saiag, P
- Lacour, J P
- Legoupil, D
- Lesimple, T
- Aubin, F
- Beylot-Barry, M
- Brunet-Possenti, F
- Arnault, J P
- Granel-Brocard, F
- Stoebner, P E
- Dupuy, A
- Maubec, E
- Grob, J J
- Dreno, B
- Rotolo, F
- Ballon, A
- Michiels, S
- Lebbe, C
- Borget, I
Producer: 20191003
In:
European journal of cancer (Oxford, England : 1990) vol. 105
Availability: No items available.
|